Dr. Jed A. Gorden, MD

Dr. Gorden practices at Swedish Medical Center -First Hill in Seattle, Washington.

Dr. Gorden's NPI, 1275630147, was assigned on September 20, 2006. Dr. Gorden graduated from Vanderbilt University School Of Medicine in 1997. Dr. Gorden's Washington license number on file is MD00037794.

Dr. Gorden's primary practice is Swedish Medical Center -First Hill, at 747 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 386-6000.

Dr. Gorden's primary practice is Swedish Medical Center -First Hill in Seattle, Washington. Dr. Gorden is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Gorden to 1 more hospital, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorden practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Gorden's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Gorden's licenses on file in 3 states: Washington, Massachusetts and Idaho.

CMS data shows 547 Medicare services from Dr. Gorden across 11 procedure codes in 2024, for 142 Medicare patients. Medicare paid $78,013 for them.

CMS counts 142 Medicare patients who saw Dr. Gorden in 2024. The largest group is 75 to 84, with 61 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gorden's median patient age at 73, with 63% women.

In 2024, Dr. Gorden wrote 30 Medicare Part D claims for 16 patients. 73% of them were for generic drugs. They cover 3 drugs, with $4,013 in total drug cost. In 2016, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gorden for performance year 2024, reported as part of a group. Dr. Gorden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gorden as offering telehealth.

Dmand AI links 63 papers to Dr. Gorden, published from 2010 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Drainage and Pleural Effusion. Dr. Gorden has published most often in Chest. Dr. Gorden's most frequent co-authors are Christopher R. Gilbert, DO, Brian E. Louie, MD and Alexander Soheil Farivar, MD.

Dmand AI links Dr. Gorden to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Emphysema and Empyema, Pleural.

CMS Open Payments shows 265 general payments to Dr. Gorden from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. AstraZeneca Pharmaceuticals LP paid the most, $206,669.

Dmand AI lists 2 awards for Dr. Gorden, most recently CMS Stage 1 EHR in 2012.

Dr. Gorden graduated from Vanderbilt University School Of Medicine in 1997.

Dr. Gorden is in network with 18 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.